Unity Biotechnology
(OTC) UBX
Unity Biotechnology Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.33M
Net Income (TTM)
$27.50M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
UBX News
UBX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Unity Biotechnology
Industry
Biotechnology
Sector
Health CareEmployees
16
CEO
Anirvan Ghosh, PhD
Website
www.unitybiotechnology.comHeadquarters
South San Francisco, CA 94080, US
UBX Financials
Key Financial Metrics (TTM)
Gross Margin
20%
Operating Margin
-16%
Net Income Margin
-17%
Return on Equity
-3%
Return on Capital
-98%
Return on Assets
-73%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$867.00K
Operating Income
$31.17M
EBITDA
$25.12M
Operating Cash Flow
$20.86M
Capital Expenditure
$0.00
Free Cash Flow
$20.86M
Cash & ST Invst.
$23.23M
Total Debt
$23.54M
Unity Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$178.00K
+21.6%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
16
N/A
Net Income
$7.30M
-26.1%
EBITDA
$6.71M
-20.7%
Quarterly Fundamentals
Net Cash
$5.67M
-155.7%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$18.68M
-17.4%
Short Term Debt
$3.90M
+10.0%
Return on Assets
-73.23%
N/A
Return on Invested Capital
-97.94%
N/A
Free Cash Flow
$6.36M
-22.7%
Operating Cash Flow
$6.36M
-22.7%